Cancer specialists unite care under one umbrella for patients, expansion
IRVING, Texas--(BUSINESS WIRE)-- Dr. Gregory A. Echt and radiation and oncology specialty teams in the North Texas area are launching a new brand to bring hope and ease-of-use to patients in North Texas and the southwest region. The group is proud to announce the formation of Choice Cancer Care, a brand with a commitment to provide the best in world-class cancer treatment options in locations convenient to patients.
“There are exciting advances in the field of oncology treatment,” said Gregory A. Echt, M.D., a board-certified radiation oncologist. “But these new alternatives mean nothing if you can’t bring them to the patients in a convenient setting that makes sense as a viable option for their care. The goal of Choice Cancer Care is to give each patient an individualized treatment care plan that takes into account all options and works with the patient, his or her family, and their lifestyle to achieve the best result possible.”
Choice Cancer Care brings together the knowledge and experience of care teams at Las Colinas Cancer Center, Southlake Oncology, North Texas Cancer Center at Wise, Lewisville/Flower Mound Oncology Group and the Prostate Seed Institute. Physician expertise includes Dr. Gregory Echt, radiation oncologist; Dr. James Mackey, hematologist/oncologist; Dr. Kiran Kancharla, hematologist/oncologist; Dr. Neeraja Dasari, radiation oncologist; and Dr. Greg Garrett, radiation oncologist. An expert nursing staff and various specialists in the wide field of cancer care round out a dedicated care team that provides all the resources needed for individuals and their families who are faced with cancer from diagnosis to after-care.
Choice Cancer Care specializes in treatment for all kinds of adult cancers, including: prostate, breast, lung, brain, throat, pancreatic and many more. Dr. Echt is well-known for pioneering prostate seed therapy (brachytherapy) in the southwest, a newer and less-invasive treatment option for some types of prostate cancer. Patients come from across the country to receive this groundbreaking treatment, which involves a complex mapping of the affected area and highly pinpointed insertion of radioactive seeds, which shrink the cancerous cells without invasive surgery and provides a viable care option for certain types of prostate cancer.
Each of the Choice Cancer Care facilities will continue to provide excellent care for their patients with the same specialized teams and staff. More information about Choice Cancer Care offices, as well as information on various types of cancer diagnoses and treatment can be found on the group’s website at www.choicecancercare.com.
CONTACT:
Choice Cancer Care
Suzanne Gentry Flodin, 214-500-4289
KEYWORDS: United States North America Texas
INDUSTRY KEYWORDS: Health Oncology Radiology Managed Care
MEDIA: